CML Healthcare

CLC-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about CLC-T

Signal
Opinion
Expert
SELL
SELL
July 8, 2013

In the midst of a take-out with Life Labs – an OMERS company. This is the reason for the pop in share price recently. The industry is consolidating. It is time to move on.

Show full opinionHide full opinion

In the midst of a take-out with Life Labs – an OMERS company. This is the reason for the pop in share price recently. The industry is consolidating. It is time to move on.

COMMENT
COMMENT
June 19, 2013

Made a big splash into the US by buying a radiology business, which didn’t work out well. Have a new CEO with a new focus. In a few months we’ll hear from the Ontario Ministry of Health with what their sentiment will be on their labs. Dividend had already been cut. He is sticking with it. 7.2% dividend yield.

Show full opinionHide full opinion

Made a big splash into the US by buying a radiology business, which didn’t work out well. Have a new CEO with a new focus. In a few months we’ll hear from the Ontario Ministry of Health with what their sentiment will be on their labs. Dividend had already been cut. He is sticking with it. 7.2% dividend yield.

COMMENT
COMMENT
May 3, 2013

Sold her holdings last year on concern about sustainability of the dividend. Focused predominantly in Canada and growing their labs business. Feels they are doing all the right things in focusing on small growth initiatives. The challenge is that they are in an industry with a lot of headwinds. Would be concerned about the sustainability of the dividend over the medium and long-term, given the lack of growth initiatives available.

Show full opinionHide full opinion

Sold her holdings last year on concern about sustainability of the dividend. Focused predominantly in Canada and growing their labs business. Feels they are doing all the right things in focusing on small growth initiatives. The challenge is that they are in an industry with a lot of headwinds. Would be concerned about the sustainability of the dividend over the medium and long-term, given the lack of growth initiatives available.

WATCH
WATCH
February 4, 2013

7.5% dividend. One of the big laboratories with 30% market share in Ontario. Recently cut dividend and they are selling some of their diagnostic assets, which he thinks are all good things. But 75% of cash flows are from medical labs. CML renegotiates contracts with the Ministry of Health and they are cutting back on healthcare. The contract is being renegotiated this year. Be cautious right now. They are doing the right things so they are coming back to the core side of their original business.

Show full opinionHide full opinion
CML Healthcare (CLC-T)
February 4, 2013

7.5% dividend. One of the big laboratories with 30% market share in Ontario. Recently cut dividend and they are selling some of their diagnostic assets, which he thinks are all good things. But 75% of cash flows are from medical labs. CML renegotiates contracts with the Ministry of Health and they are cutting back on healthcare. The contract is being renegotiated this year. Be cautious right now. They are doing the right things so they are coming back to the core side of their original business.

DON'T BUY
DON'T BUY
January 8, 2013

Doesn’t know where the management team is taking this thing. Wouldn’t be ready to jump in and buy it. There has been too much mismanagement.

Show full opinionHide full opinion
CML Healthcare (CLC-T)
January 8, 2013

Doesn’t know where the management team is taking this thing. Wouldn’t be ready to jump in and buy it. There has been too much mismanagement.

DON'T BUY
DON'T BUY
January 3, 2013

Fundamentally it has not performed well for a long time.

Show full opinionHide full opinion
CML Healthcare (CLC-T)
January 3, 2013

Fundamentally it has not performed well for a long time.

COMMENT
COMMENT
October 11, 2012

Largely in the lab testing business and their largest client is the Ontario government. Major risk is the Ontario government’s $14 billion deficit deciding that they are going to squeeze the lab companies. It will probably be another year before you know.

Show full opinionHide full opinion
CML Healthcare (CLC-T)
October 11, 2012

Largely in the lab testing business and their largest client is the Ontario government. Major risk is the Ontario government’s $14 billion deficit deciding that they are going to squeeze the lab companies. It will probably be another year before you know.

COMMENT
COMMENT
September 26, 2012

For many years they were able to live off the model of their laboratory business and contracts with the governments but Ministries of Health are getting tighter and tighter. Also, had some problems with their US exposure in radiology that didn’t work out. New management. For the time being, they tend to maintain their dividend but they would really like to lever the higher margin lab business.

Show full opinionHide full opinion
CML Healthcare (CLC-T)
September 26, 2012

For many years they were able to live off the model of their laboratory business and contracts with the governments but Ministries of Health are getting tighter and tighter. Also, had some problems with their US exposure in radiology that didn’t work out. New management. For the time being, they tend to maintain their dividend but they would really like to lever the higher margin lab business.

COMMENT
COMMENT
August 31, 2012

It was at nearly $11 and has traded down a couple of dollars. This is never a good thing. The trend is downwards. The only positive he sees is that there is a lot of volume so there is a lot of buying going on. You can buy it for the dividends but if it hits $8 then you have to get out.

Show full opinionHide full opinion
CML Healthcare (CLC-T)
August 31, 2012

It was at nearly $11 and has traded down a couple of dollars. This is never a good thing. The trend is downwards. The only positive he sees is that there is a lot of volume so there is a lot of buying going on. You can buy it for the dividends but if it hits $8 then you have to get out.

DON'T BUY
DON'T BUY
August 10, 2012

This is in a very strong sector so it is in a good neighbourhood and this is one of the poorest houses in the neighbourhood. Known a positive thing is that the low in 2011 has not been taken out. The trend is still down. Don't add to your position and if the low is taken out, start your Selling process.

Show full opinionHide full opinion
CML Healthcare (CLC-T)
August 10, 2012

This is in a very strong sector so it is in a good neighbourhood and this is one of the poorest houses in the neighbourhood. Known a positive thing is that the low in 2011 has not been taken out. The trend is still down. Don't add to your position and if the low is taken out, start your Selling process.

PAST TOP PICK
PAST TOP PICK
June 13, 2012
(A Top Pick June 15/11. Up 4.51%.) Sold his holdings at $10.50 for a 9.6% return.
Show full opinionHide full opinion
(A Top Pick June 15/11. Up 4.51%.) Sold his holdings at $10.50 for a 9.6% return.
PAST TOP PICK
PAST TOP PICK
May 11, 2012
(A Top Pick June 15/11. Up 16.52%.) Sold his holdings at $10.50 and he is now Short a little bit now. May have to cut their dividends.
Show full opinionHide full opinion
(A Top Pick June 15/11. Up 16.52%.) Sold his holdings at $10.50 and he is now Short a little bit now. May have to cut their dividends.
HOLD
HOLD
April 4, 2012
Very stable business and feels the dividend is secure. Regulated by the Ontario Ministry of Health saw has a very stable cash flow stream. About 90% payout ratio. Growth opportunities are limited so doesn't expect a ton of growth. 7.1% yield.
Show full opinionHide full opinion
Very stable business and feels the dividend is secure. Regulated by the Ontario Ministry of Health saw has a very stable cash flow stream. About 90% payout ratio. Growth opportunities are limited so doesn't expect a ton of growth. 7.1% yield.
PAST TOP PICK
PAST TOP PICK
March 12, 2012
(Top Pick Jun 15/11, Up 16.06%) Just sold it recently. The things that they thought would happen have happened. Thinks they can maintain the dividend but not sure if they can increase it.
Show full opinionHide full opinion
CML Healthcare (CLC-T)
March 12, 2012
(Top Pick Jun 15/11, Up 16.06%) Just sold it recently. The things that they thought would happen have happened. Thinks they can maintain the dividend but not sure if they can increase it.
TOP PICK
TOP PICK
February 2, 2012
Laboratory testing and medical imaging. Took a lot of risk out of their business by getting rid of their US assets. Attractive yield.
Show full opinionHide full opinion
CML Healthcare (CLC-T)
February 2, 2012
Laboratory testing and medical imaging. Took a lot of risk out of their business by getting rid of their US assets. Attractive yield.
Showing 1 to 15 of 153 entries

CML Healthcare(CLC-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for CML Healthcare is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

CML Healthcare(CLC-T) Frequently Asked Questions

What is CML Healthcare stock symbol?

CML Healthcare is a OTC stock, trading under the symbol CLC-T on the (). It is usually referred to as or CLC-T

Is CML Healthcare a buy or a sell?

In the last year, there was no coverage of CML Healthcare published on Stockchase.

Is CML Healthcare a good investment or a top pick?

CML Healthcare was recommended as a Top Pick by Andrew Hamlin on 2013-07-08. Read the latest stock experts ratings for CML Healthcare.

Why is CML Healthcare stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is CML Healthcare worth watching?

0 stock analyst on Stockchase covered CML Healthcare In the last year. It is a trending stock that is worth watching.

What is CML Healthcare stock price?

On , CML Healthcare (CLC-T) stock closed at a price of $.